Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cancer-Bio-Santé (CBS) was a French competitiveness cluster dedicated to the healthcare and life sciences sectors, primarily based in the Occitanie and Limousin regions. Established in 2005, the cluster focused on three main pillars: oncology, aging (silver economy), and digital health. It served as a catalyst for innovation by facilitating partnerships between academic researchers, clinical centers, and industrial players. The organization provided support for R&D projects, international development, and business growth for its members. In January 2019, CBS merged with Eurobiomed to form a unified health cluster in Southern France, enhancing the regional ecosystem's global competitiveness. This merger combined the strengths of the Occitanie, Provence-Alpes-Côte d'Azur, and Limousin regions to create a leading European health hub.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cancer-Bio-Sante Cluster.